龙8 - long8 (国际)唯一官方网站

Press Release

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

Mabwell Established a Licensing and Commercialization Agreement of Denosumab Biosimilars for Vietnamese Market

Dr. Liu Datao Attends "Focus on the Two Sessions · 2026 6th Ophthalmology Summit"

Mabwell Announces Strategic Partnership with MediTrust Health

Cell Reports | Mabwell collaborates with SIOC, CAS and SJTU to publish research results on a monoclonal antibody targeting α-synuclein fibrils, revealing its potential to halt Parkinson’s disease progression

Mabwell Announces First-Patient Dosed in Clinical Trial of Novel CDH17-Targeting ADC 7MW4911 in the U.S.

SynuSight Biotech, an Incubated Company of Mabwell, and ABLi Therapeutics Enter into a License Agreement for [18F]-FD4 to Advance Clinical Research for Parkinson’s Disease

Previous 1 2

【网站地图】【sitemap】